aggressive hyperinflammatory condition—who were treated with the first-in-class monoclonal antibody, ELA026, experienced a 100% response rate and an improved survival rate at two months ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...

FDA grants orphan drug designation to HLX22 for gastric cancer, with a phase 2 trial showing improved progression-free ...

The damage to blood vessels is concerning because it's how antifungal drug therapy is delivered to the infection site. "Our humanized monoclonal antibody allows antifungal drug therapy to reach to ...

TG Therapeutics (TGTX) announced the publication of two journal articles one describing the evolution of CD20 treatments for multiple sclerosis ...

“Similarly, there is an unmet medical need for treatment, a need which IgGenix is hoping to address.” IgE, which is a specific class of monoclonal antibody, triggers reactions after people are ...

In 2025, the CNS market is forecast to surpass $80bn in sales for the first time since 2013, marking a significant turnaround ...